In PSP and bvFTD, plasma EV tau ratios correlated with NfL, clinical, cognitive and behavior scales reflecting disease pathology, similar to plasma EV TDP-43 in ALS and bvFTD, including trial-relevant scales such as ALS-FRS-revised and CDR-SB. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.